150 related articles for article (PubMed ID: 33733820)
1. Role of miRNA gene variants in the susceptibility and pharmacogenetics of colorectal cancer.
Aghabozorgi AS; Sharif S; Jafarzadeh-Esfehani R; Vakili S; Abbaszadegan MR
Pharmacogenomics; 2021 Apr; 22(5):303-318. PubMed ID: 33733820
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer.
Cekaite L; Eide PW; Lind GE; Skotheim RI; Lothe RA
Oncotarget; 2016 Feb; 7(6):6476-505. PubMed ID: 26623728
[TBL] [Abstract][Full Text] [Related]
3. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
[TBL] [Abstract][Full Text] [Related]
4. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.
Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA dysregulation in colorectal cancer: a clinical perspective.
Dong Y; Wu WK; Wu CW; Sung JJ; Yu J; Ng SS
Br J Cancer; 2011 Mar; 104(6):893-8. PubMed ID: 21364594
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E
BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
9. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
[TBL] [Abstract][Full Text] [Related]
11. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation.
Ma Y; Zhang P; Yang J; Liu Z; Yang Z; Qin H
Int J Cancer; 2012 May; 130(9):2077-87. PubMed ID: 21671476
[TBL] [Abstract][Full Text] [Related]
12. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
13. A Review on the Role of Nanosensors in Detecting Cellular miRNA Expression in Colorectal Cancer.
Girigoswami K; Girigoswami A
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):12-26. PubMed ID: 32410567
[TBL] [Abstract][Full Text] [Related]
14. Identification of Differentially Expressed MicroRNAs involved in the Pathogenesis of Colorectal Cancer.
Feng H; Xu M; Zhang Y; Han B; Wang J; Sun P
Clin Lab; 2018 May; 64(5):797-804. PubMed ID: 29739047
[TBL] [Abstract][Full Text] [Related]
15. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
Hibner G; Kimsa-Furdzik M; Francuz T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
[TBL] [Abstract][Full Text] [Related]
16. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
[TBL] [Abstract][Full Text] [Related]
17. Germline miRNA DNA variants and the risk of colorectal cancer by subtype.
Lindor NM; Larson MC; DeRycke MS; McDonnell SK; Baheti S; Fogarty ZC; Win AK; Potter JD; Buchanan DD; Clendenning M; Newcomb PA; Casey G; Gallinger S; Le Marchand L; Hopper JL; Jenkins MA; Goode EL; Thibodeau SN
Genes Chromosomes Cancer; 2017 Mar; 56(3):177-184. PubMed ID: 27636879
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs expression profiling in Egyptian colorectal cancer patients.
Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M
IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372
[TBL] [Abstract][Full Text] [Related]
19. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
[TBL] [Abstract][Full Text] [Related]
20. The expression and clinical significance of microRNAs in colorectal cancer detecting.
Yang X; Zhong J; Ji Y; Li J; Jian Y; Zhang J; Yang W
Tumour Biol; 2015 Apr; 36(4):2675-84. PubMed ID: 25480414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
